Improving Medication-Related Outcomes in Chronic Liver Disease

27Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

Abstract

Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medication-related problems (MRPs) have been associated with adverse patient outcomes, including hospitalization and mortality. Factors that can contribute to MRPs in people with CLD are variable and often entwined. This narrative literature review discusses key barriers and opportunities to modify risk factors and improve medication-related outcomes for people with CLD.

Cite

CITATION STYLE

APA

Hayward, K. L., & Weersink, R. A. (2020, November 1). Improving Medication-Related Outcomes in Chronic Liver Disease. Hepatology Communications. John Wiley and Sons Inc. https://doi.org/10.1002/hep4.1612

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free